Jane Pei-Chen Chang

Dr. Jane Pei-Chen Chang

College of Medicine of Medicine, China Medical University, Taichung, Taiwan
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

25 June 2011 in Social Psychiatry and Psychiatric Epidemiology
Verified
Journal Article
Closed access
PDF file
Takahiro A. KatoTakahiro A. Kato
Takahiro A. Kato
MTMasaru Tateno
Masaru Tateno
NSNaotaka Shinfuku
Naotaka Shinfuku
DFDaisuke Fujisawa
Daisuke Fujisawa
ATAlan R. Teo
Alan R. Teo
SKShigenobu Kanba
Shigenobu Kanba

11 September 2023 in Psychiatry and Clinical Neurosciences
Verified
Journal Article
Open access
SCSzu-Wei Cheng
Szu-Wei Cheng
CCChung‐Wen Chang
Chung‐Wen Chang
WCWan-Jung Chang
Wan-Jung Chang
HWHao‐Wei Wang
Hao‐Wei Wang
CLChih-Sung Liang
Chih-Sung Liang
KSKuan-Pin Su
Kuan-Pin Su
ChatGPT has sparked extensive discussions within the healthcare community since its November 2022 release. However, potential applications in the field of psychiatry have received limited attention. Deep learning has proven beneficial to psychiatry, and GPT is a powerful deep learning‐based language model with immense potential for this field. Despite the convenience of ChatGPT, this advanced chatbot currently has limited practical applications in psychiatry. It may be used to support psychiatrists in routine tasks such as completing medical records, facilitating communications between clinicians and with patients, polishing academic writings and presentations, and programming and performing analyses for research. The current training and application of ChatGPT require using appropriate prompts to maximize appropriate outputs and minimize deleterious inaccuracies and phantom errors. Moreover, future GPT advances that incorporate empathy, emotion recognition, personality assessment, and detection of mental health warning signs are essential for its effective integration into psychiatric care. In the near future, developing a fully‐automated psychotherapy system trained for expert communication (such as psychotherapy verbatim) is conceivable by building on foundational GPT technology. This dream system should integrate practical ‘real world’ inputs and friendly AI user and patient interfaces via clinically validated algorithms, voice comprehension/generation modules, and emotion discrimination algorithms based on facial expressions and physiological inputs from wearable devices. In addition to the technology challenges, we believe it is critical to establish generally accepted ethical standards for applying ChatGPT‐related tools in all mental healthcare environments, including telemedicine and academic/training settings.

1 October 2014 in Biological Psychiatry
Verified
Journal Article
Closed access
KSKuan-Pin Su
Kuan-Pin Su
HLHsueh-Chou Lai
Hsueh-Chou Lai
HYHui-Ting Yang
Hui-Ting Yang
WSWen-Pang Su
Wen-Pang Su
CPCheng-Yuan Peng
Cheng-Yuan Peng
CPCarmine M. Pariante
Carmine M. Pariante


19 August 2021 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
Jane Pei-Chen ChangJane Pei-Chen Chang
Jane Pei-Chen Chang
KSKuan-Pin Su
Kuan-Pin Su
VMValeria Mondelli
Valeria Mondelli
CPCarmine M. Pariante
Carmine M. Pariante
Several studies reported abnormal cortisol and inflammatory biomarker levels in youths with attention deficit hyperactivity disorder (ADHD), but the results have not been conclusive. We conducted a systematic review followed by a meta-analysis of case-control studies assessing blood or saliva cortisol levels and blood levels of inflammatory biomarkers in youth with ADHD. The effect sizes (ES) were synthesized by using a random-effects model. In the 19 studies on cortisol levels (totaling n = 916 youth with ADHD and n = 947 typically developing (TD), healthy youth), youth with ADHD have lower basal cortisol levels at any time-points during the day (effect size: .68; p = 0.004) and lower cumulative levels of cortisol (ES: .39, p = .008) throughout the day than TD youth. Moreover, morning cortisol levels were lower in ADHD youth when compared with TD youth (14 studies, n = 1679, ES: .84, p = 0.003), while there is no difference for the afternoon cortisol levels (p = 0.48). The meta-analysis on inflammation biomarker was conducted on 4 studies (totaling n = 404 youth) showed that Tumour Necrosis Factor-alpha (TNF-α) was lower in ADHD when compared with TD (3 studies, n = 257 youth, p = 0.004), while no differences for Interleukin-1β(IL-1β) (p = 0.21), IL-6 (p = 0.09) and IL-10 (p = 0.77). The lower cortisol in the context of low TNF-α levels may indicate a specific pattern of biomarkers in ADHD, and further investigation is warranted.